Hong Kong, China

Simon Siu Man Ng


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon Siu Man Ng: Innovator in Colorectal Cancer Diagnosis and Treatment

Introduction

Simon Siu Man Ng is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of medical diagnostics, particularly in colorectal cancer. His innovative work has led to the development of a method that aids in the diagnosis and prognosis of this prevalent disease.

Latest Patents

Simon Siu Man Ng holds a patent for a groundbreaking invention titled "Tumor suppressor VSTM2A as a biomarker for colorectal cancer." This invention provides a method for diagnosing and determining the prognosis of colorectal cancer in a subject by detecting suppressed expression of the VSTM2A gene. In some cases, this suppression is attributed to elevated methylation levels in the genomic sequence of the gene. The patent also includes a kit and device useful for implementing this diagnostic method. Furthermore, it outlines a method for treating colorectal cancer by increasing VSTM2A gene expression or activity. He has 1 patent to his name.

Career Highlights

Simon Siu Man Ng is affiliated with The Chinese University of Hong Kong, where he continues to advance research in cancer diagnostics and treatment. His work is characterized by a commitment to improving patient outcomes through innovative medical solutions.

Collaborations

Simon has collaborated with notable colleagues in his field, including Jun Yu and Joseph Jao Yiu Sung. Their combined expertise contributes to the ongoing research and development of effective cancer therapies.

Conclusion

Simon Siu Man Ng is a key figure in the fight against colorectal cancer, with his innovative patent providing valuable tools for diagnosis and treatment. His contributions to medical science are paving the way for improved patient care and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…